This company listing is no longer active
Ectin Research 過去の業績
過去 基準チェック /06
Ectin Research's earnings have been declining at an average annual rate of -29.3%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 84.5% per year.
主要情報
-29.3%
収益成長率
-24.1%
EPS成長率
| Pharmaceuticals 業界の成長 | 30.5% |
| 収益成長率 | -84.5% |
| 株主資本利益率 | n/a |
| ネット・マージン | n/a |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
収支内訳
Ectin Research の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -18 | 9 | 0 |
| 31 Mar 24 | 0 | -17 | 8 | 0 |
| 31 Dec 23 | 0 | -17 | 8 | 0 |
| 30 Sep 23 | 0 | -9 | -1 | 0 |
| 30 Jun 23 | 0 | -12 | 1 | 0 |
| 31 Mar 23 | 0 | -14 | 14 | 0 |
| 31 Dec 22 | 0 | -13 | 13 | 0 |
| 30 Sep 22 | 0 | -12 | 4 | 0 |
| 30 Jun 22 | 0 | -13 | 5 | 0 |
| 31 Mar 22 | 0 | -12 | 4 | 0 |
| 31 Dec 21 | 1 | -12 | 1 | 0 |
| 31 Aug 20 | 2 | -1 | 0 | 0 |
| 31 Aug 19 | 1 | -1 | 0 | 0 |
| 31 Aug 18 | 1 | 0 | 0 | 0 |
質の高い収益: ECTIN B is currently unprofitable.
利益率の向上: ECTIN B is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: ECTIN B is unprofitable, and losses have increased over the past 5 years at a rate of 29.3% per year.
成長の加速: Unable to compare ECTIN B's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: ECTIN B is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (4.3%).
株主資本利益率
高いROE: ECTIN B's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.